Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Interstitial lung disease (ILD) is the primary cause of death in patients with systemic sclerosis (SSc). It is thought that chronic inflammation is a key component in SSc-ILD. Treatment, such as cyclophosphamide (CYC), targets this inflammation. We hypothesized that treatment with CYC might be more...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Rheumatol
Asıl Yazarlar: van den Hombergh, W. M. T., Simons, S. O., Teesselink, E., Knaapen-Hans, H. K. A., van den Hoogen, F. H. J., Fransen, J., Vonk, M. C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer London 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154086/
https://ncbi.nlm.nih.gov/pubmed/29987427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-018-4171-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller